ErbB-3 activation by NRG-1β sustains growth and promotes vemurafenib resistance in BRAF-V600E colon cancer stem cells (CSCs)
Pramudita R. Prasetyanti(Academic Medical Center), Gianluca Sala(University of Chieti-Pescara)
Cited by 36
Related Papers
Intra-tumor heterogeneity from a cancer stem cell perspective
|Molecular Cancer|2017|828
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma
|Journal of Controlled Release|2018|38
Extracellular <scp>LGALS3BP</scp> : a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma
|Molecular Oncology|2023|36